Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1

Fig. 4

Forest plot of progression-free survival subgroup analysis (investigator assessment). a Asian subset. b Non-Asian subset. The hazard ratios were obtained using a non-stratified Cox proportional hazard model. *The majority of patients were from Asia. Due to small numbers, region is not displayed within Fig. 4. CRF case report form, ECOG PS Eastern Cooperative Oncology Group performance status, adj adjuvant, diag. diagnosis, EU Europe, IWRS interactive voice and web response system, LA Latin America, NA North America, neo-adj neoadjuvant, recur recurrence

Back to article page